European Primary Care Cardiovascular Society

Striking results for weight reduction in T2DM in primary care based program

Dec. 18, 2017 - IDF 2017 - Abu Dhabi, UAE - Prof Naveed Sattar, MD - Glasgow, UK

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

Nov. 20, 2017 - AHA 2017 - Anaheim, CA, USA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

Good BP measurement depends more on appropriate technique than on absence of staff

Nov. 25, 2017 - AHA 2017 - Anaheim, CA, USA - Prof Karen Johnson - Memphis, TN, VS

Things to consider when aiming to prevent stroke in a patient with AF

May 25, 2017

What can be learned from the latest hypertension trials?

May 26, 2017

Heart failure diagnosis and management varies substantially across European countries

May 25, 2017

How do the latest guideline changes affect management of dyslipidaemia in primary care?

May 26, 2017

Ingredients of effective strategies to stimulate behaviour change

May 25, 2017

The evidence base for health behaviour changes

Dec. 9, 2015 - EPCCS 2015 - Prague, Czech Republic

Identifying and treating patients with true hypertension

Feb. 24, 2016 - Prague - EPCCS 2015

What is the evidence base for lipid modification in the guidelines updates?

Feb. 24, 2016 - Prague - EPCCS 2015

Heart failure diagnosis and management

Dec. 9, 2015 - EPCCS 2015 - Prague

​Stroke prevention in atrial fibrillation

Mar. 12, 2014 - Amsterdam - Hobbs, Rutten

The EPCCS Stroke Prevention in Atrial Fibrillation Guidance Document 1

Jan. 7, 2014 - EPCCS 2014, Brussels - Prof. David Fitzmaurice

What's the evidence for BP and lipid targets in diabetes?

Nov. 25, 2014 - EPCCS 2014, Brussels

Debate: should we treat lifetime risk or 10-year risk?

Nov. 25, 2014 - Brussels, Belgium - Prof R. Hobbs, Th. Christiaens, C.Brotons & A. Hoes - EPCCS 2014

Alcohol as a risk factor for hypertension

Nov. 20, 2014 - Brussels, Belgium - Prof. Daniel Duprez (Minnesota, USA) - EPCCS 2014

Reducing weight and increasing exercise - is it feasible?

Nov. 20, 2014 - Brussels, Belgium - Dr. Ian Campbell - EPCCS 2014

CVD and co-morbidities: What are the priorities? 1

Nov. 20, 2014 - EPCCS Brussels - Dr Geert-Jan Geersingh - EPCCS 2014

Diagnosis and management of acute coronary syndromes

Nov. 18, 2014 - Brusselss, Belgium - Dr. Frans Rutten - EPCCS 2014

Increased mortality and morbidity risk in older ischemic stroke patients with diabetes

Feb. 21, 2018 - Echouffo-Tcheugui JB, et al. - Eur Heart J 2018

In patients with ischemic stroke ≥ 65 years, diabetes is associated with a higher risk of mortality, recurrent events, HF and hospitalisations.

Over time increased physical activity associated with reduced HF risk

Feb. 21, 2018 - Florido R, et al. - Circulation 2018

In a community-based population without baseline CVD, increasing physical activity over 6 years was associated with reduced heart failure risk over the next two decades.

Chronické srdcové zlyhávanie

EPCCS Guidance translations

Download the Slovak document on CHF management in primary care.

Prevencia cievnej mozgovej príhody u pacientov s fibriláciou predsiení

EPCCS Guidance translations

Download the Slovak document on Prevention of stroke in patients with AF and screening of AF.

Практична настанова по діагностиці та менеджменту серцевої недостатності в системі первинної медичної допомоги

EPCCS Guidance translations

Download the Ukrainian version of the EPCCS Practical Guidance on Heart Failure Diagnosis and Management in Primary Care.

Novel GLP-1 analogue in once-weekly formula receives EU approval as T2DM therapy

Feb. 12, 2018 - news

The European Commission has granted marketing authorization for semaglutide as monotherapy or in combination with other agents, for the treatment of adults with type 2 diabetes.

No association of omega-3 fatty acid supplements with CV risk reduction

Feb. 12, 2018 - Aung T, et al. - JAMA Cardiol 2018

A large meta-analysis showed that omega-3 fatty acid supplementation is not associated with a reduction in fatal and non-fatal CHD and other major vascular events.

‘Metabolically healthy obese’ persons are still at higher CHD risk, thus not so healthy after all

Feb. 7, 2018 - Lassale C et al., - Eur Heart J, 2018

A large pan-European study shows that overweight and obesity are associated with higher risk of CHD, even if the person does not have metabolic syndrome.

How can EPCCS expand its membership?

EPCCS Council

Feb. 6, 2018

Read about ideas that came up during a brainstorm during the EPCCS Council workshop on how EPCCS might reach more members and thus form a stronger network between European GPs.

How can the EPCCS better engage with primary care physicians in various European countries regarding cardiovascular disease education?

EPCCS Council

Feb. 6, 2018

Read our plans and future ambitions in a summary of the EPCCS Council workshop on how EPCCS can support and inform general practitioners across Europe.

No safe level of smoking exists when it comes to CVD

Feb. 1, 2018 - Hackshaw A, et al. - BMJ 2018

The relation between smoking and CV risk is non-lineair: smoking 1 cigarette/day is associated with 30-50% of the excess risk of coronary heart disease and stroke when smoking 20 cigarettes/day.

Higher resting heart rate and increased changes therein over time associated with adverse outcomes

Feb. 1, 2018 - Vazir A, et al. - JAMA Cardiol 2018

In a community-based cohort, higher resting heart rate and increased changes in resting heart rate over time were associated with mortality, incident heart failure, myocardial infarction, and stroke.